Bassendine M. F. Wright N. A. Thomas H. C. Sherlock S. Growth characteristics of alpha-foetoprotein-secreting human hepatocellular carcinoma in athymic (nude) mice. 64 6 6 1983 643 648 Clin Sci (Lond) 6188573 10.1042/cs0640643
Baxter M. A. Chahwala S. B. Hickman J. A. Spurgin G. E. The effects of nitrogen mustard (HN2) on activities of the plasma membrane of PC6A mouse plasmacytoma cells. 31 9 1 5 1982 1773 1778 Biochem Pharmacol 6213233 10.1016/0006-2952(82)90683-9
Beardwell C. G. Hindley A. C. Wilkinson P. M. Todd I. D. Ribeiro G. G. Bu'Lock D. Trilostane in the treatment of advanced breast cancer. 10 3 1983 158 160 Cancer Chemother Pharmacol 6861259 10.1007/BF00255752
Beattie G. M. Knowles A. F. Jensen F. C. Baird S. M. Kaplan N. O. Induction of sarcomas in athymic mice. 79 9 5 1982 3033 3036 Proc Natl Acad Sci U S A PMC346343 6283553 10.1073/pnas.79.9.3033
Bertino J. R. Sawicki W. L. Cashmore A. R. Cadman E. C. Skeel R. T. Natural resistance to methotrexate in human acute nonlymphocytic leukemia. 61 4 7 1977 667 673 Cancer Treat Rep 267508
Bloom B. R. Interferons and the immune system. 284 5757 17 4 1980 593 595 Nature 6154245 10.1038/284593a0
Bosanquet A. G. Bird M. C. Price W. J. Gilby E. D. An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia. 47 6 6 1983 781 789 Br J Cancer PMC2011362 6190492 10.1038/bjc.1983.131
Carney D. N. Gazdar A. F. Minna J. D. Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small-cell carcinoma of the lung. 40 6 6 1980 1820 1823 Cancer Res 6245805
Colby W. W. Shenk T. Fragments of the simian virus 40 transforming gene facilitate transformation of rat embryo cells. 79 17 9 1982 5189 5193 Proc Natl Acad Sci U S A PMC346860 6291029 10.1073/pnas.79.17.5189
Connors T. A. Goddard P. M. Merai K. Ross W. C. Wilman D. E. Tumour inhibitory triazenes: structural requirements for an active metabolite. 25 3 1 2 1976 241 246 Biochem Pharmacol 1267820 10.1016/0006-2952(76)90207-0
Courtenay V. D. Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. 37 2 2 1978 261 268 Br J Cancer PMC2009601 343804 10.1038/bjc.1978.35
Courtenay V. D. Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. 37 2 2 1978 261 268 Br J Cancer PMC2009601 343804 10.1038/bjc.1978.35
Courtenay V. D. Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. 37 2 2 1978 261 268 Br J Cancer PMC2009601 343804 10.1038/bjc.1978.35
Creissen D. Shall S. Regulation of DNA ligase activity by poly(ADP-ribose). 296 5854 18 3 1982 271 272 Nature 6278323 10.1038/296271a0
Deuel T. F. Huang J. S. Huang S. S. Stroobant P. Waterfield M. D. Expression of a platelet-derived growth factor-like protein in simian sarcoma virus transformed cells. 221 4618 30 9 1983 1348 1350 Science 6310754 10.1126/science.6310754
Droller M. J. Schneider M. U. Perlmann P. A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells. 39 1 8 1978 165 177 Cell Immunol 699056 10.1016/0008-8749(78)90091-6
Friedman H. M. Glaubiger D. L. Assessment of in vitro drug sensitivity of human tumor cells using [3H]thymidine incorporation in a modified human tumor stem cell assay. 42 11 11 1982 4683 4689 Cancer Res 7127304
Funa K. Alm G. V. Rönnblom L. Oberg K. Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon. 53 3 9 1983 716 724 Clin Exp Immunol PMC1535658 6616963
Goldfarb P. S. O'Prey J. Affara N. Yang Q. S. Harrison P. R. Isolation of non-globin genes expressed preferentially in mouse erythroid cells. 11 11 11 6 1983 3517 3530 Nucleic Acids Res PMC325983 6190134 10.1093/nar/11.11.3517
Heldin C. H. Westermark B. Wasteson A. Chemical and biological properties of a growth factor from human-cultured osteosarcoma cells: resemblance with platelet-derived growth factor. 105 2 11 1980 235 246 J Cell Physiol 6936400 10.1002/jcp.1041050207
Herberman R. B. Immunoregulation and natural killer cells. 19 10 10 1982 1313 1321 Mol Immunol 6184615 10.1016/0161-5890(82)90299-1
Hudig D. Haverty T. Fulcher C. Redelman D. Mendelsohn J. Inhibition of human natural cytotoxicity by macromolecular antiproteases. 126 4 4 1981 1569 1574 J Immunol 6970780
Isaacson P. G. Jones D. B. Immunohistochemical differentiation between histiocytic and lymphoid neoplasms. 15 7 7 1983 621 635 Histochem J 6350232 10.1007/BF01002984
Kadish A. S. Doyle A. T. Steinhauer E. H. Ghossein N. A. Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease. 127 5 11 1981 1817 1822 J Immunol 6170674
Kasturi K. Fleming J. Harrison P. A monoclonal antibody against erythrocyte spectrin reacts with both alpha- and beta-subunits and detects spectrin-like molecules in non-erythroid cells. 144 1 3 1983 241 247 Exp Cell Res 6188624 10.1016/0014-4827(83)90462-7
Koren H. S. Anderson S. J. Fischer D. G. Copeland C. S. Jensen P. J. Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins. 127 5 11 1981 2007 2013 J Immunol 6170683
Lee F. Y. Workman P. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice. 47 5 5 1983 659 669 Br J Cancer PMC2011404 6849803 10.1038/bjc.1983.104
Matthews P. N. Grant A. G. Hermon-Taylor J. The growth of human bladder and kidney cancers as xenografts in nude mice and rats. 10 6 1982 293 299 Urol Res 7157564 10.1007/BF00255876
McElwain T. J. Powles R. L. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. 2 8354 8 10 1983 822 824 Lancet 6137651 10.1016/s0140-6736(83)90739-0
Morson B. President's address. The polyp-cancer sequence in the large bowel. 67 6 Pt 1 6 1974 451 457 Proc R Soc Med PMC1645739 4853754 10.1177/00359157740676P115
Müller H. J. A simple fluorescence staining technique for the differentiation of human tissue transplanted into nude mice. 51 6 11 1976 287 291 Stain Technol 64003 10.3109/10520297609116726
Pross H. F. Baines M. G. Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease. 18 5 15 11 1976 593 604 Int J Cancer 825477 10.1002/ijc.2910180508
Simms E. Gazdar A. F. Abrams P. G. Minna J. D. Growth of human small cell (oat cell) carcinoma of the lung in serum-free growth factor-supplemented medium. 40 12 12 1980 4356 4363 Cancer Res 6254644
Spencer A. F. Lowenstein J. M. Citrate content of liver and kidney of rat in various metabolic states and in fluoroacetate poisoning. 103 2 5 1967 342 348 Biochem J PMC1270414 6032977 10.1042/bj1030342
Steel G. G. Courtenay V. D. Rostom A. Y. Improved immune-suppression techniques for the exongrafting of human tumours. 37 2 2 1978 224 230 Br J Cancer PMC2009576 343803 10.1038/bjc.1978.30
Steel G. G. Courtenay V. D. Rostom A. Y. Improved immune-suppression techniques for the exongrafting of human tumours. 37 2 2 1978 224 230 Br J Cancer PMC2009576 343803 10.1038/bjc.1978.30
Steinhauer E. H. Doyle A. T. Reed J. Kadish A. S. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease. 129 5 11 1982 2255 2259 J Immunol 7119445
Takasugi M. Ramseyer A. Takasugi J. Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression. 37 2 2 1977 413 418 Cancer Res 832266
Taylor-Papadimitriou J. Purkis P. Lane E. B. McKay I. A. Chang S. E. Effects of SV40 transformation on the cytoskeleton and behavioural properties of human keratinocytes. 11 3 5 1982 169 180 Cell Differ 6180835 10.1016/0045-6039(82)90008-2
Wagstaff J. Gibson C. Thatcher N. Ford W. L. Sharma H. Crowther D. Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observations. 43 3 3 1981 443 449 Clin Exp Immunol PMC1537191 7285388
Workman P. Twentyman P. R. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU. 46 2 8 1982 249 259 Br J Cancer PMC2011106 7150475 10.1038/bjc.1982.190